Glioblastoma patients treated with Nivolumab and Bevacizumab: Evidence of activated - and Nivolumab-binding T cells in tumor tissue

S. Skadborg; S. Maarup; A. Draghi; A. Borch; I. Svane; B. Hasselbalch; H. Skovgaard Poulsen; U. Lassen; S. Hadrup

Glioblastoma patients treated with Nivolumab and Bevacizumab: Evidence of activated - and Nivolumab-binding T cells in tumor tissue

S. Skadborg, S. Maarup, A. Draghi, A. Borch, I. Svane, B. Hasselbalch, H. Skovgaard Poulsen, U. Lassen, S. Hadrup

Research output: Contribution to journal › Conference abstract in journal › Research › peer-review

Original language	English
Journal	Scandinavian Journal of Immunology
Volume	94
Issue number	6
ISSN	0300-9475
Publication status	Published - 2021

OpenUrl availability

Full text

Cite this

@article{61abbe9f94eb4ed4b396c60ffb1f8773,

title = "Glioblastoma patients treated with Nivolumab and Bevacizumab: Evidence of activated - and Nivolumab-binding T cells in tumor tissue",

author = "S. Skadborg and S. Maarup and A. Draghi and A. Borch and I. Svane and B. Hasselbalch and {Skovgaard Poulsen}, H. and U. Lassen and S. Hadrup",

year = "2021",

language = "English",

volume = "94",

journal = "Scandinavian Journal of Immunology, Supplement",

issn = "0300-9475",

publisher = "Wiley-Blackwell",

number = "6",

}

TY - ABST

T1 - Glioblastoma patients treated with Nivolumab and Bevacizumab: Evidence of activated - and Nivolumab-binding T cells in tumor tissue

AU - Skadborg, S.

AU - Maarup, S.

AU - Draghi, A.

AU - Borch, A.

AU - Svane, I.

AU - Hasselbalch, B.

AU - Skovgaard Poulsen, H.

AU - Lassen, U.

AU - Hadrup, S.

PY - 2021

Y1 - 2021

M3 - Conference abstract in journal

SN - 0300-9475

VL - 94

JO - Scandinavian Journal of Immunology, Supplement

JF - Scandinavian Journal of Immunology, Supplement

IS - 6

ER -